Subject: Brand name aspirin
From: Chris Maeda <chrismaeda@yahoo.com>
Date: Sun, 10 Oct 1999 16:31:15 -0700 (PDT)

>In the US, brand name and generic drugs must be -- by

>law -- functionally identical.  I saw two packages
>with the same dosage, same coating, and same count, 
>that differed in price by over a factor of two.  If 
>it works for aspirin, I shouldn't be surprised it 
>works for software.  My amplifier goes to 11.

This is a little naive.  Intellectual property
is different from molecules.  Two different 
development organizations cannot produce identical
pieces of software any more than two bands can
produce identical pieces of music.





=====
Chris Maeda (cmaeda@alum.mit.edu)
__________________________________________________
Do You Yahoo!?
Bid and sell for free at http://auctions.yahoo.com